Literature DB >> 19079277

Sugary drinks in the pathogenesis of obesity and cardiovascular diseases.

C M Brown1, A G Dulloo, J-P Montani.   

Abstract

Soft drink overconsumption is now considered to be a major public health concern with implications for cardiovascular diseases. This follows a number of studies performed in animals suggesting that chronic consumption of refined sugars can contribute to metabolic and cardiovascular dysregulation. In particular, the monosaccharide fructose has been attracting increasing attention as the more harmful sugar component in terms of weight gain and metabolic disturbances. High-fructose corn syrup is gradually replacing sucrose as the main sweetener in soft drinks and has been blamed as a potential contributor to the current high prevalence of obesity. There is also considerable evidence that fructose, rather than glucose, is the more damaging sugar component in terms of cardiovascular risk. This review focuses on the potential role of sugar drinks, particularly the fructose component, in the pathogenesis of obesity and cardiovascular diseases.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19079277     DOI: 10.1038/ijo.2008.204

Source DB:  PubMed          Journal:  Int J Obes (Lond)        ISSN: 0307-0565            Impact factor:   5.095


  35 in total

1.  Increased hepatic de novo lipogenesis and mitochondrial efficiency in a model of obesity induced by diets rich in fructose.

Authors:  Raffaella Crescenzo; Francesca Bianco; Italia Falcone; Paola Coppola; Giovanna Liverini; Susanna Iossa
Journal:  Eur J Nutr       Date:  2012-04-28       Impact factor: 5.614

Review 2.  Perspective: Cardiovascular Responses to Sugar-Sweetened Beverages in Humans: A Narrative Review with Potential Hemodynamic Mechanisms.

Authors:  Cathriona R Monnard; Erik Konrad Grasser
Journal:  Adv Nutr       Date:  2018-03-01       Impact factor: 8.701

3.  High beverage sugar as well as high animal protein intake at infancy may increase overweight risk at 8 years: a prospective longitudinal pilot study.

Authors:  Peter J m Weijs; Laura M Kool; Nicolien M van Baar; Saskia C van der Zee
Journal:  Nutr J       Date:  2011-09-23       Impact factor: 3.271

4.  Alterations of naltrexone-induced conditioned place avoidance by pre-exposure to high fructose corn syrup or heroin in Sprague-Dawley rats.

Authors:  Stephen Daniels; Paul Marshall; Francesco Leri
Journal:  Psychopharmacology (Berl)       Date:  2015-10-30       Impact factor: 4.530

Review 5.  A possible link between hepatic mitochondrial dysfunction and diet-induced insulin resistance.

Authors:  Raffaella Crescenzo; Francesca Bianco; Arianna Mazzoli; Antonia Giacco; Giovanna Liverini; Susanna Iossa
Journal:  Eur J Nutr       Date:  2016-02       Impact factor: 5.614

6.  The Clustering of Lifestyle Behaviours in New Zealand and their Relationship with Optimal Wellbeing.

Authors:  Kate B Prendergast; Lisa M Mackay; Grant M Schofield
Journal:  Int J Behav Med       Date:  2016-10

Review 7.  The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome.

Authors:  Jung Sub Lim; Michele Mietus-Snyder; Annie Valente; Jean-Marc Schwarz; Robert H Lustig
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-04-06       Impact factor: 46.802

8.  Timing of fructose intake: an important regulator of adiposity.

Authors:  Mariana Morris; Iara C Araujo; Roberta L Pohlman; Mariana C Marques; Naima S Rodwan; Vera M A Farah
Journal:  Clin Exp Pharmacol Physiol       Date:  2012-01       Impact factor: 2.557

9.  Physical activity, sedentary behaviors and dietary habits among Saudi adolescents relative to age, gender and region.

Authors:  Hazzaa M Al-Hazzaa; Nada A Abahussain; Hana I Al-Sobayel; Dina M Qahwaji; Abdulrahman O Musaiger
Journal:  Int J Behav Nutr Phys Act       Date:  2011-12-21       Impact factor: 6.457

10.  Sugar-sweetened carbonated beverage consumption correlates with BMI, waist circumference, and poor dietary choices in school children.

Authors:  Kate S Collison; Marya Z Zaidi; Shazia N Subhani; Khalid Al-Rubeaan; Mohammed Shoukri; Futwan A Al-Mohanna
Journal:  BMC Public Health       Date:  2010-05-09       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.